- Senior Lecturer in Biochemistry and Cell Biology, University College Cork
Increasing skills and the availability of raw materials would be a bigger boost for vaccine production right now.
A transcript of The Conversation Weekly podcast episode #3.
While some of the authorised COVID-19 vaccines are grown, others are built.
Plus new research on why China is closing down coal-fired power stations. Listen to episode 3 of The Conversation Weekly.
We still need to know exactly what part of the immune response offers protection – and how strong it needs to be to remain protective.
Interim analysis of trial data isn’t unusual – but leaves us with many things we still need to find out.
An unprecedented level of research has gone into understanding the novel coronavirus. Here’s what we still don’t know.
Les données sur l’innocuité sont acceptables, même avec une forte dose. Le vaccin est donc sûr, du moins chez les personnes en bonne santé âgées de 18 à 60 ans, mais il reste à savoir s’il fonctionne.
Tim Rusia menunjukkan bahwa vaksin mereka menghasilkan tingkat antibodi tinggi yang dapat mengikat protein paku. Namun, hal yang lebih penting adalah apakah tingkatan antibodi ini berguna.
Another day, another politicised vaccine.
Contact Anne for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined









